<DOC>
	<DOCNO>NCT03019887</DOCNO>
	<brief_summary>To reduce antipsychotic 1000mg patient schizophrenia take 1000mg/day evaluate relationship relapse cognitive function .</brief_summary>
	<brief_title>Correlation Between Cognitive Function Relapse Schizophrenia Regarding Dose Reduction High-dose Antipsychotic Therapy</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Perphenazine</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Methotrimeprazine</mesh_term>
	<criteria>inpatient diagnosis schizophrenial , chronic phase receive mean daily antipsychotic dos exceed 1000mg CPZ eq./day . mental retardation , substance abuse dependence , history major head trauma , serious medical neurological disorder , depot antipsychotic injection within previous 3 month electroconvulsive therapy within previous 6 month</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>